Strategic partnerships Bourne Partners operates two synergistic business segments, Investment Banking and Strategic Capital, with a track record of collaborating with major firms such as Cerberus, The Carlyle Group, Covis Pharma, Millicent Pharma, and Blackstone. This presents opportunities to position advisory and investment services to large PE firms and strategic buyers seeking healthcare deals.

Healthcare focus The firm specializes in pharma, pharma services, healthcare services, and consumer health, indicating a deep domain expertise. This makes Bourne Partners a strong candidate for targeted engagements in M&A advisory, licensing, partnering opportunities, and capital raises within global healthcare sectors.

Carlin platform Recent and ongoing Carlin Consumer Health initiatives show a dedicated consumer health investment strategy with multiple sponsors. This opens doors for deal sourcing, co-investment opportunities, and strategic collaborations in consumer health brands and related services.

International collaboration Past engagements include partnerships with global players like Blackstone and MannKind, suggesting receptivity to cross-border transactions and international market expansion. This can be leveraged to pursue international deal pipelines and global access programs for health products.

Small to mid cap focus With revenue in the 10M-25M range and a midsize firm profile (51-200 employees), Bourne Partners appears positioned to assist growth-stage healthcare companies in capital raises, private placements, and strategic exits, targeting mid-market opportunities where their specialized industry knowledge adds value.